Cime Therapeutics Inc. — Form D

Cime Therapeutics Inc. of DENVER, CO, a company, filed a Form D exempt-offering notice with the SEC on 2025-03-21. The offering totals $2.5M, of which $2.1M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2025-03-21
• Form: D
• Accession: 0002062575-25-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $2.5M
• Amount sold: $2.1M
• Remaining: $400K
• Investors: 3
• Date of first sale: 2025-03-14
• Revenue range: Decline to Disclose
• SEC file number: 021-541875

Issuer

• Name: Cime Therapeutics Inc.
• CIK: 0002062575
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2024
• Address: 110 16TH STREET, DENVER, CO, 80202
• Phone: 760-703-5380

Officers, directors & promoters (3)

More

• CIK 2062575 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search